Marker Therapeutics, Inc. Reports annual revenue of $3.3 million
Company Records $8.2 million loss
By USInMinutes
Published - Mar 26, 2024, 10:19 PM ET
Last Updated - Mar 26, 2024, 10:19 PM EDT
Marker Therapeutics, Inc. [MRKR] has reported $3.3 million in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $8.2 million.
